The prevalence and regional variation of major depressive disorder among patients with peripheral arterial disease in the medicare population

Vascular and Endovascular Surgery

Volumn 50, Issue 4, 2016, Pages 235-240

  Columbo, Jesse A ^a   Stone, David H ^a   Goodney, Philip P ^a   Nolan, Brian W ^a   Stableford, Jennifer A ^a   Brooke, Benjamin S ^b   Powell, Richard J ^a   Finn, Christine T ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

major depression; peripheral arterial disease; regional variation; risk factors

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ALGORITHM; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; ICD-9; MAJOR DEPRESSION; MEDICARE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; RESOURCE ALLOCATION; ADMINISTRATIVE CLAIMS (HEALTH CARE); AGED; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; ENDEMIC DISEASE; FACTUAL DATABASE; PERIPHERAL ARTERIAL DISEASE; PSYCHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; UNITED STATES;

ADMINISTRATIVE CLAIMS, HEALTHCARE; AGED; COMORBIDITY; DATABASES, FACTUAL; DEPRESSIVE DISORDER, MAJOR; ENDEMIC DISEASES; HUMANS; LINEAR MODELS; MEDICARE; PERIPHERAL ARTERIAL DISEASE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84966479872     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574416644529     Document Type: Article

References (28)

1. Rozanski A, Blumenthal JA, Kaplan J,. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999; 99 (16): 2192-2217.
2. Malhotra S, Tesar GE, Franco K,. The relationship between depression and cardiovascular disorders. Curr Psychiatry Rep. 2000; 2 (3): 241-246.
3. Smolderen KG, Safley DM, House JA, Spertus JA, Marso SP,. Percutaneous transluminal angioplasty: association between depressive symptoms and diminished health status benefits. Vascular Med. 2011; 16 (4): 260-266.
4. Haschke A, Hutter N, Baumeister H,. Indirect costs in patients with coronary artery disease and mental disorders: a systematic review and meta-analysis. Int J Occup Med Environ Health. 2012; 25 (4): 319-329.
5. Dempe C, Junger J, Hoppe S, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. J Psychosom Res. 2013; 74 (2): 122-127.
6. Goldstein BI, Carnethon MR, Matthews KA, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015; 132 (10): 965-986.
7. Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002; 288 (6): 701-709.
8. O'Connor CM, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 2010; 56 (9): 692-699.
9. Damen NL, Versteeg H, Boersma E, et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry. Int J Cardiol. 2013; 167 (6): 2496-2501.
10. Mendes de Leon CF, Czajkowski SM, Freedland KE, et al. The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial. J Cardiopulm Rehabil. 2006; 26 (1): 9-13; quiz 4-5.
11. Joynt KE, O'Connor CM., Lessons from SADHART, ENRICHD, and other trials. Psychosom Med. 2005; 67 (suppl 1): S63-S66.
12. Cherr GS, Wang J, Zimmerman PM, Dosluoglu HH,. Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization. J Vasc Surg. 2007; 45 (4): 744-750.
13. Cherr GS, Zimmerman PM, Wang J, Dosluoglu HH,. Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization. J Gen Intern Med. 2008; 23 (5): 629-634.
14. Center for Medicare and Medicaid Services. Web site. www.cms.gov. Accessed September 9, 2014.
15. Goodney PP, Holman K, Henke PK, et al. Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg. 2013; 57 (6): 1471-1479,. 1480.e1-e3; discussion 1479-1480.
16. Suckow BD, Goodney PP, Nolan BW, et al. Domains that determine quality of life in vascular amputees. Ann Vasc Surg. 2015; 29 (4): 722-730.
17. Smolderen KG, Hoeks SE, Pedersen SS, van Domburg RT, de L II, Poldermans D,. Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia. Vasc Med. 2009; 14 (4): 297-304.
18. Smolderen KG, Aquarius AE, de Vries J, Smith OR, Hamming JF, Denollet J,. Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors. J Affect Disord. 2008; 110 (1-2): 27-35.
19. Toda N, Nakanishi-Toda M,. How mental stress affects endothelial function. Pflugers Arch. 2011; 462 (6): 779-794.
20. Wattanakit K, Williams JE, Schreiner PJ, Hirsch AT, Folsom AR,. Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study. Vasc Med. 2005; 10 (3): 199-206.
21. Ohira T, Diez Roux AV, Polak JF, Homma S, Iso H, Wasserman BA,. Associations of anger, anxiety, and depressive symptoms with carotid arterial wall thickness: the multi-ethnic study of atherosclerosis. Psychosom Med. 2012; 74 (5): 517-525.
22. Chen H, Zhang L, Zhang M, et al. Relationship of depression, stress and endothelial function in stable angina patients. Physiology Behavior. 2013; 118: 152-158.
23. Wulsin LR, Evans JC, Vasan RS, Murabito JM, Kelly-Hayes M, Benjamin EJ,. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med. 2005; 67 (5): 697-702.
24. Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL,. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013; 2013: 695925.
25. Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA,. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003; 290 (2): 215-221.
26. McDermott MM, Greenland P, Guralnik JM, et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med. 2003; 18 (6): 461-467.
27. Oulis P, Kouzoupis A, Kyrkou K, et al. Reversal of increased arterial stiffness in severely depressed women after 6-week antidepressant treatment. J Affect Disord. 2010; 122 (1-2): 164-166.
28. Mazereeuw G, Herrmann N, Bennett SA, et al. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. Neurosci Biobehav Rev. 2013; 37 (8): 1611-1621.